TrialInvestigational new drugs2019

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.

Hao Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.